Kiora Pharmaceuticals, Inc. Share Price

Kiora Pharmaceuticals, Inc. Share Price

NASDAQ: KPRX | Micro Cap
$1.56
-$0.20 (-11.36%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kiora Pharmaceuticals, Inc. Stock Performance

Open
$1.75
Prev. Close
$1.76
Circuit Range
N/A
Day Range
$1.55 - $1.75
Year Range
$1.55 - $2.89
Volume
1,518
Average Traded
$1.58

Kiora Pharmaceuticals, Inc. Share Price Today

As of 31 October 2026, Kiora Pharmaceuticals, Inc.'s share price is $1.56. The stock opened at $1.75, compared to its previous close of $1.76. During today's trading session, Kiora Pharmaceuticals, Inc.'s share price traded between $1.55 and $1.75, with an average price of $1.65. Over the past 52 weeks, the stock has recorded a high of $2.89 and a low of $1.55. In terms of performance, Kiora Pharmaceuticals, Inc.'s share price has declined by 33.90% over the last six months and is down 30.67% on a year-on-year basis.

Kiora Pharmaceuticals, Inc. Share Price Chart

Line chart of the Kiora Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 1.55 to 1.75, ending at 1.56.
$1.55$1.75
L
Show Current Price
H

Kiora Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$6.50M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-65.18%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-7033.33%

Kiora Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$0.03-$6.52-$2.42-$2.08
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-21833.33%62.88%14.05%

Kiora Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$16.02$0.00
Net Profit-$13.58-$13.04$3.59-$10.84
Net Profit MarginN/AN/A22.41%N/A
Income ChangeN/A3.98%127.53%-401.95%

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Kiora Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.55
$1.60
-41.18%
Sep 2026
$2.54
$2.72
+3.82%
Aug 2026
$2.61
$2.62
+5.22%
Jul 2026
$2.67
$2.49
-4.41%
Jun 2026
$2.71
$2.60
-4.58%
May 2026
$2.40
$2.73
+15.68%
Apr 2026
$1.90
$2.36
+24.87%
Mar 2026
$2.02
$1.89
-7.35%
Feb 2026
$2.40
$2.04
-14.47%
Jan 2026
$1.99
$2.38
+22.31%
Dec 2025
$1.92
$1.95
+2.63%
Nov 2025
$2.42
$1.90
-15.56%

KPRX Share Price FAQs